Evidence map›Paper›PMID 31441896›Full record

ArticleMedicine2019

Probiotics supplement for the prevention of eczema in children: Study protocol for a meta-analysis and systematic review.

Wenhao Yang, Renyuan Tu, Yanan Hu, Tao He, Weijian Zhang, Li Gu, Hanmin Liu

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04265716 (Topical Lactobacillus Reuteri DSM 17938 to Evaluate Safety and Efficacy on Children With Mild or Moderate Atopic Dermatitis), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04265716 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Topical Lactobacillus Reuteri DSM 17938 to Evaluate Safety and Efficacy on Children With Mild or Moderate Atopic Dermatitis

TypeinterventionalSponsorInnovacion y Desarrollo de Estrategias en SaludRan2020 to 2020Enrolled102ConditionsAtopic DermatitisArmsTopical L. reeuteri
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Probiotics Function in Preventing Atopic Dermatitis in Children.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Wenhao YangDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu.
Renyuan TuWest China Hospital/West China School of Medicine.
Yanan HuDepartment of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Tao HeDepartment of Breast Surgery, West China Hospital/West China School of Medicine, Sichuan University, Chengdu.
Weijian ZhangDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu.
Li GuDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu.
Hanmin LiuDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu.
West China Second University Hospital of Sichuan University · CNAffiliated Hospital of Southwest Medical University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtopic dermatitis (AD), also called eczema, is one of the most familiar chronic diseases in childhood. A possible pathological mechanism is immune dysfunction resulting in IgE sensitization to allergens. The recent studies demonstrated that the immune system can be affected by probiotics or prebiotics. However, the effectiveness and safety of probiotics or prebiotics on prevention of eczema are still unclear. To investigate this question, we conduct a systematic review and meta-analysis.

methodsThe protocol followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. Four main databases (PubMed, Embase, the Cochrane Library, and the web of science) will be searched dating until 15 July 2019 for randomized controlled trials investigating the effects and safety of probiotics or prebiotics on prevention of eczema in children with no language restrictions. In addition, a manual search of the references of relevant published studies will also be considered.Studies selection, data extraction, and risk of bias assessment will be conducted by two independent reviewers. The primary outcome is the incidence of eczema. The second outcome is adverse events. The duration of intervention, the timing of intervention and intervention organism will be taken into consideration.

resultsThe results will provide useful information about the effect and safety of probiotics or prebiotics on reducing the incidence of eczema in children.

conclusionThe findings of this study will be published in a peer-reviewed journal.PROSPERO registration number: CRD42019136528.

Indexed as

AdultChildDermatitis, AtopicEczemaFemaleHumansMaleMeta-Analysis as TopicPregnancyProbioticsRandomized Controlled Trials as TopicSystematic Reviews as Topic

Identifiers

PMID31441896
PMCPMC6716687
OpenAlexW2969622630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.